Indian pharma firm Caplin Point Labs up on higher Q3 profit

Caplin Point Laboratories

12/02/2024 06:44

** Shares of Caplin Point Laboratories  CAPL.NS  rise 5% to
1,502 rupees
    ** The pharma co said on Friday its Q3 consol net profit
rose 20%, rev from ops up 17% Y/Y
    ** EBITDA margin expanded to 35.2% from 32% year ago
    ** More than 183,000 shares change hands, 1.3x its 30-day
avg
    ** CAPL up ~5% so far this month, on track for fourth
consecutive month of gains
    ** Stock gained ~32% in Dec-quarter, its third straight
quarterly gain


 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))